GGrantIndex
← Leaderboards

Johanna Patricia Daily

Harvard University (Sch Of Public Hlth)

$8,890,442
Attributed
$10,374,354
Total exposure
10
Grants
9
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.5M · FY200525
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$10,374,354 · 10

By mechanism

R01$6,740,255 · 3
U19$1,320,950 · 1
R21$1,165,690 · 3
K23$622,620 · 1
RC1$499,999 · 1
D71$24,840 · 1

Top collaborators

Others in their field

Top investigators on “Infection

Research focus

InfectionMalariaPlasmodium FalciparumMorbidity - Disease RateChildParasitesLaboratoriesSymptomsReportingBaseResponseBiologyFutureIn VitroBrainComaImmune ResponseClinical ResearchSamplingPathogenPathogenesisIn VivoNeurologicCollaborations

Grant awards (31)

Characterizing Persistent Subclinical Neurobehavioral Effects of COVID-19 in a Diverse Urban Population$622,584
R01 · FY2025 · NS · contact PI
Defining the mechanism of coma in cerebral malaria$525,866
R01 · FY2025 · AI · contact PI
Role of cytolytic ZEB2+ memory CD4+ T cells in protection against liver stage malaria$244,440
R21 · FY2025 · AI
Characterizing Persistent Subclinical Neurobehavioral Effects of COVID-19 in a Diverse Urban Population$672,352
R01 · FY2024 · NS · contact PI
Defining the mechanism of coma in cerebral malaria$527,997
R01 · FY2024 · AI · contact PI
Characterizing persistent subclinical neurobehavioral effects of COVID-19 in a diverse urban population$690,928
R01 · FY2023 · NS · contact PI
Defining the mechanism of coma in cerebral malaria$540,538
R01 · FY2023 · AI · contact PI
Characterizing persistent subclinical neurobehavioral effects of COVID-19 in a diverse urban population$712,681
R01 · FY2022 · NS
Defining the mechanism of coma in cerebral malaria$529,291
R01 · FY2022 · AI · contact PI
Identifying adjunctive therapy in the experimental model of malaria to improve cerebral malaria outcomes$210,000
R21 · FY2022 · AI · contact PI
Identifying adjunctive therapy in the experimental model of malaria to improve cerebral malaria outcomes$252,000
R21 · FY2021 · AI · contact PI
Plasmodium phospholipase A2s as potential novel drug targets$208,750
R21 · FY2020 · AI · contact PI
Plasmodium phospholipase A2s as potential novel drug targets$250,500
R21 · FY2019 · AI · contact PI
Role of type INF I during mild Plasmodium falciparum infection and association w$262,715
U19 · FY2016 · AI · contact PI
Role of type INF I during mild Plasmodium falciparum infection and association w$288,670
U19 · FY2015 · AI · contact PI
Role of type INF I during mild Plasmodium falciparum infection and association w$251,796
U19 · FY2014 · AI · contact PI
Role of type INF I during mild Plasmodium falciparum infection and association w$268,098
U19 · FY2013 · AI · contact PI
Analysis of novel in vivo derived Plasmodium falciparum transcriptional profiles$391,864
R01 · FY2012 · AI · contact PI
Role of type INF I during mild Plasmodium falciparum infection and association w$249,671
U19 · FY2012 · AI · contact PI
Analysis of novel in vivo derived Plasmodium falciparum transcriptional profiles$390,570
R01 · FY2011 · AI · contact PI
Host immune response to malaria infection$499,999
RC1 · FY2010 · AI · contact PI
Analysis of novel in vivo derived Plasmodium falciparum transcriptional profiles$394,515
R01 · FY2010 · AI · contact PI
Ethippian Integrated Malaria Research Training Programs Planning Grant$24,840
D71 · FY2010 · TW · contact PI
Analysis of novel in vivo derived Plasmodium falciparum transcriptional profiles$361,600
R01 · FY2009 · AI · contact PI
Analysis of novel in vivo derived Plasmodium falciparum transcriptional profiles$203,315
R01 · FY2008 · AI · contact PI
Analysis of novel in vivo derived Plasmodium falciparum transcriptional profiles$176,154
R01 · FY2008 · AI · contact PI
Drug resistance in Plasmodium falciparum$124,524
K23 · FY2007 · AI · contact PI
Drug resistance in Plasmodium falciparum$124,524
K23 · FY2006 · AI · contact PI
Drug resistance in Plasmodium falciparum$124,524
K23 · FY2005 · AI
Drug resistance in Plasmodium falciparum$124,524
K23 · FY2004 · AI
Drug resistance in Plasmodium falciparum$124,524
K23 · FY2003 · AI